Patient Enrollment

Related by string. * PATIENTS . PATIENT . Patients . pa tients . patients : Breast Cancer Patients . terminally ill patients . Patient Safety . Improving Patient Outcomes . chronically ill patients / Enrollments . ENROLLMENT . enrollments . enrollment : Enrollment Rx . Defense Enrollment Eligibility . Concurrent Enrollment . Declining enrollment * Completes Patient Enrollment *

Related by context. Frequent words. (Click for all words.) 85 Phase III Trial 84 Phase III Clinical Trial 83 Completes Enrollment 82 Clinical Trial Results 82 Drug Candidate 82 Pivotal Phase III 81 Pivotal Trial 81 FDA Accepts 80 Pivotal Phase 80 Generic Version 79 Presents Positive 79 Preclinical Data 78 FDA Clears 78 Cholesterol Drug 77 Initiate Phase 76 II Clinical Trial 76 Prostate Cancer Patients 75 Metastatic Melanoma 75 Receives FDA Clearance 75 FDA Clearance 75 Well Tolerated 74 Initiates Phase 74 Positive Opinion 74 Heart Failure Patients 73 RNAi Therapeutics 73 Announces Initiation 73 Metastatic Colorectal Cancer 73 Study Demonstrates 73 Chronic Hepatitis C 73 Patients Treated 73 Pulmonary Arterial Hypertension 72 Patent Covering 72 Blood Thinner 72 Vertex Pharmaceuticals Announces 72 Significantly Reduces 72 Breast Cancer Treatment 72 Lung Cancer Patients 72 Smallpox Vaccine 71 Elderly Patients 71 Overactive Bladder 71 Drug Resistant 71 Monotherapy 71 Monoclonal Antibody 71 Advanced Prostate Cancer 71 Announces Presentation 71 FY# Guidance 71 Prostate Cancer Treatment 71 Cervical Cancer Vaccine 71 Gastric Cancer 70 Patients Undergoing 70 Inc Therapeutic Competitors 70 Patient Outcomes 70 Reduces Risk 70 Malaria Vaccine 70 Venous Thromboembolism 70 Achieves Milestone 70 Clinical Study 70 Shows Promise 70 Q1 Loss Narrows 70 Combination Therapy 70 Postmenopausal Women 70 Recombinant Human 70 Small Molecule 70 Transcept Pharmaceuticals 70 Aliskiren 70 Pirfenidone 70 FDA Approves 70 Cancer Treatments 70 Drug Eluting Stent 69 Benign Prostatic Hyperplasia 69 Explore Strategic Alternatives 69 Diabetic Patients 69 Cethromycin 69 Hormone Therapy 69 FDA Approval 69 Annual Meeting Date 69 Reports Positive 69 Clinical Trial 69 Autoimmune Disease 69 Provides Guidance 69 Receives Positive 69 Non Invasive 68 Record Third Quarter 68 FDA Orphan Drug 68 Successful Completion 68 Diabetic Macular Edema 68 Low Dose 68 Cetrorelix 68 Announces Positive 68 Diet Pill 68 Cancer Vaccines 68 k Clearance 68 Epratuzumab 68 Announces Publication 68 Drug Eluting Stents 68 Guidance Quick Facts 68 Panzem R 68 Q3 Loss Widens 68 Rexahn Pharmaceuticals 68 Allergic Rhinitis 68 Atopic Dermatitis

Back to home page